DRIO vs. XAIR, LYRA, PAVM, QIPT, TELA, BWAY, KRMD, BLUA, SRTS, and HSAQ
Should you be buying DarioHealth stock or one of its competitors? The main competitors of DarioHealth include Beyond Air (XAIR), Lyra Therapeutics (LYRA), PAVmed (PAVM), Quipt Home Medical (QIPT), TELA Bio (TELA), BrainsWay (BWAY), KORU Medical Systems (KRMD), BlueRiver Acquisition (BLUA), Sensus Healthcare (SRTS), and Health Sciences Acquisitions Co. 2 (HSAQ). These companies are all part of the "surgical & medical instruments" industry.
DarioHealth (NASDAQ:DRIO) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, media sentiment, profitability, risk, earnings and community ranking.
Beyond Air has a net margin of 0.00% compared to DarioHealth's net margin of -282.38%. DarioHealth's return on equity of -76.11% beat Beyond Air's return on equity.
Beyond Air has lower revenue, but higher earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.
DarioHealth has a beta of 1.5, indicating that its share price is 50% more volatile than the S&P 500. Comparatively, Beyond Air has a beta of 0.01, indicating that its share price is 99% less volatile than the S&P 500.
DarioHealth received 194 more outperform votes than Beyond Air when rated by MarketBeat users. However, 68.75% of users gave Beyond Air an outperform vote while only 67.04% of users gave DarioHealth an outperform vote.
DarioHealth currently has a consensus price target of $4.05, indicating a potential upside of 249.14%. Beyond Air has a consensus price target of $9.33, indicating a potential upside of 646.67%. Given Beyond Air's higher probable upside, analysts clearly believe Beyond Air is more favorable than DarioHealth.
In the previous week, Beyond Air had 1 more articles in the media than DarioHealth. MarketBeat recorded 2 mentions for Beyond Air and 1 mentions for DarioHealth. DarioHealth's average media sentiment score of 1.89 beat Beyond Air's score of 0.94 indicating that DarioHealth is being referred to more favorably in the media.
33.4% of DarioHealth shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 15.7% of DarioHealth shares are owned by insiders. Comparatively, 19.0% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
DarioHealth beats Beyond Air on 8 of the 15 factors compared between the two stocks.
Get DarioHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for DRIO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DRIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
DarioHealth Competitors List
Related Companies and Tools
